Tuesday, 02 January 2024 12:17 GMT

Imdx To Participate In Lake Street 10Th Annual Best Ideas Growth“BIG10” Conference


(MENAFN- GlobeNewsWire - Nasdaq) NASHVILLE, Tenn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced participation in the upcoming Lake Street Capital Markets 10th Annual Best Ideas Growth“BIG10” Conference taking place September 10th, 2026 in New York.

Event: Lake Street Capital Markets 10th Annual Best Ideas Growth“BIG10” Conference
Who: Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James
Date: Thursday, September 10, 2026
Location: Metropolitan Club, New York City
Format: One-on-one meetings
Investors wishing to meet with IMDX management are encouraged to reach out to their Lake Street sales representative.

About Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit for more information.

GraftAssureCoreTM, GraftAssureIQTM, GraftAssureDxTM, VitaGraftTM, GraftAssureTM, DetermaIOTM, and DetermaCNITM are trademarks of Insight Molecular Diagnostics Inc.

Investor Contact:
Alexandra Grossman
LifeSci Advisors LLC
...


MENAFN02092026004107003653ID1111611994



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story